Balancing cell cycle arrest and immune activation: A synergistic window for idasanutlin and anti-PD-1 therapy in a syngeneic mouse model. - Nieznanska A; Statkiewicz M; Sandowska-Markiewicz Z; Unrug-Bielawska K; Majewska A; Kocik-Krol J; Czepiel M; Galuszka-Bulaga A; Mikula M; Ostrowski J; Holak TA; Skalniak L (Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025)